<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37328773</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants.</ArticleTitle><Pagination><StartPage>124</StartPage><MedlinePgn>124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-023-02061-8</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection leading to Coronavirus Disease 2019 (COVID-19) has caused more than 762&#xa0;million infections worldwide, with 10-30% of patients suffering from post-acute sequelae of SARS-CoV-2 infections (PASC). Initially thought to primarily affect the respiratory system, it is now known that SARS-CoV-2 infection and PASC can cause dysfunction in multiple organs, both during the acute and chronic stages of infection. There are also multiple risk factors that may predispose patients to worse outcomes from acute SARS-CoV-2 infection and contribute to PASC, including genetics, sex differences, age, reactivation of chronic viruses such as Epstein Barr Virus (EBV), gut microbiome dysbiosis, and behavioral and lifestyle factors, including patients' diet, alcohol use, smoking, exercise, and sleep patterns. In addition, there are important social determinants of health, such as race and ethnicity, barriers to health equity, differential cultural perspectives and biases that influence patients' access to health services and disease outcomes from acute COVID-19 and PASC. Here, we review risk factors in acute SARS-CoV-2 infection and PASC and highlight social determinants of health and their impact on patients affected with acute and chronic sequelae of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Chumeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ramasamy</LastName><ForeName>Akshara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verduzco-Gutierrez</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of Texas at San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brode</LastName><ForeName>W Michael</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, TX, USA. Esther.melamed@austin.utexas.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NIAAA K08 T26-1616-11</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Social determinants</Keyword></KeywordList><CoiStatement>Chumeng Wang: Nothing to disclose; Akshara Ramasamy: Nothing to disclose; Monica Verduzco-Gutierrez: has received honoraria for PASC presentations, and has served as a consultant for Merz, Ipsen, and AbbVie. W. Michael Brode: has received honoraria for PASC presentations, and served as a consultant for Intrivo Diagnostics. Esther Melamed: has received NIH funding for COVID-19 research and received honorarium from the National Center for Health Research for PASC presentation, has served on advisory boards of Genentech, Horizon, Teva and Viela Bio.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>16</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328773</ArticleId><ArticleId IdType="pmc">PMC10276420</ArticleId><ArticleId IdType="doi">10.1186/s12985-023-02061-8</ArticleId><ArticleId IdType="pii">10.1186/s12985-023-02061-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19.) Dashboard [Internet]. [cited 2023 Apr 9]. Available from: https://covid19.who.int.</Citation></Reference><Reference><Citation>CDC. COVID-19 and Your Health [Internet]. Cent. Dis. Control Prev. 2020 [cited 2022 Aug 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html.</Citation></Reference><Reference><Citation>A clinical case definition of post COVID-19. condition by a Delphi consensus, 6 October 2021 [Internet]. [cited 2022 Aug 4]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC, Post. -COVID Conditions [Internet]. Cent. Dis. Control Prev. 2022 [cited 2022 Aug 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Choo SY. The HLA System: Genetics, Immunology, Clinical Testing, and clinical implications. Yonsei Med J. 2007;48:11&#x2013;23. doi: 10.3349/ymj.2007.48.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2007.48.1.11</ArticleId><ArticleId IdType="pmc">PMC2628004</ArticleId><ArticleId IdType="pubmed">17326240</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontiers | HLA. Immune Response, and Susceptibility to COVID-19 [Internet]. [cited 2022 Aug 9]. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.601886/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu</ArticleId><ArticleId IdType="pmc">PMC7820778</ArticleId><ArticleId IdType="pubmed">33488597</ArticleId></ArticleIdList></Reference><Reference><Citation>Uncoupling the Roles of HLA-DRB1. and HLA-DRB5 Genes in Multiple Sclerosis | The Journal of Immunology [Internet]. [cited 2022 Oct 17]. Available from: https://www.jimmunol.org/content/181/8/5473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4346327</ArticleId><ArticleId IdType="pubmed">18832704</ArticleId></ArticleIdList></Reference><Reference><Citation>Four Systemic Lupus Erythematosus Subgroups., Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations - Diaz&#x2010;Gallo &#x2013; 2022 - ACR Open Rheumatology - Wiley Online Library [Internet]. [cited 2022 Oct 17]. Available from: https://onlinelibrary.wiley.com/doi/10.1002/acr2.11343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754019</ArticleId><ArticleId IdType="pubmed">34658170</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol Nature Publishing Group. 2022;23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses | Free Full-Text. | Clinical Manifestation of Subacute Thyroiditis Triggered by SARS-CoV-2 Infection Can Be HLA-Dependent [Internet]. [cited 2022 Oct 17]. Available from: https://www.mdpi.com/1999-4915/13/12/2447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8707017</ArticleId><ArticleId IdType="pubmed">34960716</ArticleId></ArticleIdList></Reference><Reference><Citation>HLA-dependent variation in SARS&#x2010;CoV&#x2010;2 CD. 8 + T cell cross&#x2010;reactivity with human coronaviruses - Buckley &#x2013; 2022 - Immunology - Wiley Online Library [Internet]. [cited 2022 Oct 17]. Available from: https://onlinelibrary.wiley.com/doi/10.1111/imm.13451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111820</ArticleId><ArticleId IdType="pubmed">35143694</ArticleId></ArticleIdList></Reference><Reference><Citation>Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol. 2001;1:983&#x2013;93. doi: 10.1016/S1567-5769(01)00044-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1567-5769(01)00044-3</ArticleId><ArticleId IdType="pubmed">11407317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M, Brizzolara R, Atzeni F, Capellino S, Straub RH, Puttini PCS. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36&#x2013;42. doi: 10.1111/j.1749-6632.2009.05383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.05383.x</ArticleId><ArticleId IdType="pubmed">20398006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system - A spotlight on the role of progestogens. Autoimmun Rev. 2015;14:536&#x2013;42. doi: 10.1016/j.autrev.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.02.004</ArticleId><ArticleId IdType="pubmed">25697984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsa A, Prabhu JS. Gender disparity in COVID-19: role of sex steroid hormones. Asian Pac J Trop Med. 2021;14:5&#x2013;9. doi: 10.4103/1995-7645.304293.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1995-7645.304293</ArticleId><ArticleId IdType="pmc">PMC7610540</ArticleId><ArticleId IdType="pubmed">33828641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L, Burkert FR, Thommes L, Egger A, Hoermann G, Kaser S, et al. Testosterone Deficiency is a risk factor for severe COVID-19. Front Endocrinol. 2021;12:694083. doi: 10.3389/fendo.2021.694083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.694083</ArticleId><ArticleId IdType="pmc">PMC8253686</ArticleId><ArticleId IdType="pubmed">34226825</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P, Gregori S, Tassara M, Boeri L, et al. Severely low testosterone in males with COVID-19: a case-control study. Andrology. 2021;9:1043&#x2013;52. doi: 10.1111/andr.12993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12993</ArticleId><ArticleId IdType="pmc">PMC8013327</ArticleId><ArticleId IdType="pubmed">33635589</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Ann Oncol Off J Eur Soc Med Oncol. 2020;31:1040&#x2013;5. doi: 10.1016/j.annonc.2020.04.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.04.479</ArticleId><ArticleId IdType="pmc">PMC7202813</ArticleId><ArticleId IdType="pubmed">32387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontiers. | The Double Edge Sword of Testosterone&#x2019;s Role in the COVID-19 Pandemic [Internet]. [cited 2022 Aug 8]. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2021.607179/full.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009245</ArticleId><ArticleId IdType="pubmed">33796068</ArticleId></ArticleIdList></Reference><Reference><Citation>Travison TG, Morley JE, Araujo AB, O&#x2019;Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in Aging Men. J Clin Endocrinol Metab. 2006;91:2509&#x2013;13. doi: 10.1210/jc.2005-2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2005-2508</ArticleId><ArticleId IdType="pubmed">16670164</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkin J. Erectile dysfunction and hypogonadism (low testosterone). Can J Urol. 2011;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21501544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. Multidisciplinary Digital Publishing Institute; 2022;11:413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, Truchis P. de. Post&#x2013;COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. Elsevier; 2020;26:1448&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection. : A Cross-sectional Multicenter Study in Wuhan, China | Clinical Infectious Diseases | Oxford Academic [Internet]. [cited 2022 Aug 8]. Available from: https://academic.oup.com/cid/article/72/9/e240/5875093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454316</ArticleId><ArticleId IdType="pubmed">32697835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sund M, Fonseca-Rodr&#xed;guez O, Josefsson A, Welen K, Fors Connolly A-M. Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study. BMJ Open. 2022;12:e053032. doi: 10.1136/bmjopen-2021-053032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053032</ArticleId><ArticleId IdType="pmc">PMC8844968</ArticleId><ArticleId IdType="pubmed">35165090</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrogen. and COVID-19 symptoms: Associations in women from the COVID Symptom Study | PLOS ONE [Internet]. [cited 2022 Aug 8]. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0257051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432854</ArticleId><ArticleId IdType="pubmed">34506535</ArticleId></ArticleIdList></Reference><Reference><Citation>Sex differences in. immune responses | Nature Reviews Immunology [Internet]. [cited 2022 Aug 8]. Available from: https://www.nature.com/articles/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306659</ArticleId><ArticleId IdType="pubmed">32572247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tukiainen T, Villani A-C, Yen A, Rivas MA, Marshall JL, Satija R, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550:244&#x2013;8. doi: 10.1038/nature24265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24265</ArticleId><ArticleId IdType="pmc">PMC5685192</ArticleId><ArticleId IdType="pubmed">29022598</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17&#x3b2;-oestradiol-dependent and sex chromosome-independent. Biol Sex Differ. 2010;1:6. doi: 10.1186/2042-6410-1-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2042-6410-1-6</ArticleId><ArticleId IdType="pmc">PMC3010099</ArticleId><ArticleId IdType="pubmed">21208466</ArticleId></ArticleIdList></Reference><Reference><Citation>Matz KM, Guzman RM, Goodman AG. Chapter Two - The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders. In: Vanpouille-Box C, Galluzzi L, editors. Int Rev Cell Mol Biol [Internet]. Academic Press; 2019 [cited 2022 Aug 8]. p.&#xa0;35&#x2013;136. Available from: https://www.sciencedirect.com/science/article/pii/S1937644818300868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445394</ArticleId><ArticleId IdType="pubmed">30904196</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, Mej&#xed;a JE, Chaumeil J, Gu&#xe9;ry J-C. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol. 2019;41:153&#x2013;64. doi: 10.1007/s00281-018-0712-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0712-y</ArticleId><ArticleId IdType="pubmed">30276444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fk H, F P-R, Sr G, Bd J, Sv K, Cl N et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PloS One [Internet]. PLoS One; 2020 [cited 2022 Sep 15];15. Available from: https://pubmed.ncbi.nlm.nih.gov/33152008/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644030</ArticleId><ArticleId IdType="pubmed">33152008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnadurai R, Ogedengbe O, Agarwal P, Money-Coomes S, Abdurrahman AZ, Mohammed S, et al. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr. 2020;20:409. doi: 10.1186/s12877-020-01803-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01803-5</ArticleId><ArticleId IdType="pmc">PMC7563906</ArticleId><ArticleId IdType="pubmed">33066750</ArticleId></ArticleIdList></Reference><Reference><Citation>Age-specific mortality and immunity patterns of SARS-CoV-. 2 | Nature [Internet]. [cited 2022 Aug 8]. Available from: https://www.nature.com/articles/s41586-020-2918-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Age-dependent effects in the transmission and control of COVID-19. epidemics | Nature Medicine [Internet]. [cited 2022 Aug 8]. Available from: https://www.nature.com/articles/s41591-020-0962-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference><Reference><Citation>Attributes and predictors of long COVID. | Nature Medicine [Internet]. [cited 2022 Aug 8]. Available from: https://www.nature.com/articles/s41591-021-01292-y.</Citation></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health - Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. Elsevier; 2021;9:1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med Nature Publishing Group; 2022;1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the Inpatient and Outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37:1988&#x2013;95. doi: 10.1007/s11606-022-07523-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzellos S, Farrell PJ. Epstein-Barr Virus sequence Variation&#x2014;Biology and Disease. Pathogens. 2012;1:156&#x2013;75. doi: 10.3390/pathogens1020156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens1020156</ArticleId><ArticleId IdType="pmc">PMC4235690</ArticleId><ArticleId IdType="pubmed">25436768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules. Volume 11. Multidisciplinary Digital Publishing Institute; 2021. p. 1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470332</ArticleId><ArticleId IdType="pubmed">34572593</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr Virus infection. Ann Intern Med American College of Physicians. 1985;102:7&#x2013;16. doi: 10.7326/0003-4819-102-1-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-1-7</ArticleId><ArticleId IdType="pubmed">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein&#x2013;Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11:10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021;104:315&#x2013;9. doi: 10.1016/j.ijid.2020.12.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.051</ArticleId><ArticleId IdType="pmc">PMC7833117</ArticleId><ArticleId IdType="pubmed">33359064</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 associated EBV reactivation and effects. of ganciclovir treatment - Meng &#x2013; 2022 - Immunity, Inflammation and Disease - Wiley Online Library [Internet]. [cited 2022 Aug 9]. Available from: https://onlinelibrary.wiley.com/doi/10.1002/iid3.597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959425</ArticleId><ArticleId IdType="pubmed">35349757</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh C, Burnham KL, Ansari MA, de Cesare M, Golubchik T, Hutton P, et al. Epstein-Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype. Sci Rep Nature Publishing Group. 2020;10:9838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299986</ArticleId><ArticleId IdType="pubmed">32555213</ArticleId></ArticleIdList></Reference><Reference><Citation>Libert N, Bigaillon C, Chargari C, Bensalah M, Muller V, Merat S, et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J. 2015;38:70&#x2013;6. doi: 10.4103/2319-4170.132905.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2319-4170.132905</ArticleId><ArticleId IdType="pubmed">25179711</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigation of Long COVID Prevalence and Its Relationship to Epstein-. Barr Virus Reactivation - PMC [Internet]. [cited 2022 Aug 9]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233978/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple early factors anticipate post-acute COVID. -19 sequelae: Cell [Internet]. [cited 2022 Aug 8]. Available from: https://www.cell.com/cell/fulltext/S0092-8674(22)00072-1#secsectitle0020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau T-M, Munter SE, Ryder D, Buck A, Beck-Engeser G et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest [Internet]. American Society for Clinical Investigation; 2023 [cited 2023 Apr 8];133. Available from: https://www.jci.org/articles/view/163669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain T, Kosiorek HE, Grys TE, Kung ST, Shah VS, Betcher JA, et al. Single dose versus multiple doses of rituximab for preemptive therapy of Epstein&#x2013;Barr virus reactivation after hematopoietic cell transplantation. Leuk Lymphoma Taylor &amp; Francis. 2019;60:110&#x2013;7. doi: 10.1080/10428194.2018.1459603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10428194.2018.1459603</ArticleId><ArticleId IdType="pubmed">29979906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JI. Optimal treatment for chronic active Epstein-Barr Virus Disease. Pediatr Transpl. 2009;13:393&#x2013;6. doi: 10.1111/j.1399-3046.2008.01095.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3046.2008.01095.x</ArticleId><ArticleId IdType="pmc">PMC2776035</ArticleId><ArticleId IdType="pubmed">19032417</ArticleId></ArticleIdList></Reference><Reference><Citation>Trappe R, Riess H, Anagnostopoulos I, Neuhaus R, G&#xe4;rtner BC, Pohl H, et al. Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone. Ann Hematol. 2009;88:167&#x2013;72. doi: 10.1007/s00277-008-0538-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-008-0538-0</ArticleId><ArticleId IdType="pubmed">18636261</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D, Reitmeier S, Koyumdzhieva P, Lahmer T, Middelhoff M, Erber J, et al. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Volume 14. Gut Microbes. Taylor &amp; Francis; 2022. p. 2031840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut microbiota dynamics in. a prospective cohort of patients with post-acute COVID-19 syndrome | Gut [Internet]. [cited 2022 Aug 9]. Available from: https://gut.bmj.com/content/71/3/544.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>de Faria Coelho-Ravagnani C, Corgosinho FC, Sanches FLFZ, Prado CMM, Laviano A, Mota JF. Dietary recommendations during the COVID-19 pandemic. Nutr Rev. 2020;nuaa067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454801</ArticleId><ArticleId IdType="pubmed">32653930</ArticleId></ArticleIdList></Reference><Reference><Citation>Diet quality and risk and severity of COVID-19. : a prospective cohort study | Gut [Internet]. [cited 2022 Aug 9]. Available from: https://gut.bmj.com/content/70/11/2096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500931</ArticleId><ArticleId IdType="pubmed">34489306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Rebholz CM, Hegde S, LaFiura C, Raghavan M, Lloyd JF, et al. Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case&#x2013;control study in six countries. BMJ Nutr Prev Health. 2021;4:257&#x2013;66. doi: 10.1136/bmjnph-2021-000272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000272</ArticleId><ArticleId IdType="pmc">PMC8219480</ArticleId><ArticleId IdType="pubmed">34308134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha&#xdf; U, Herpich C, Norman K. Anti-inflammatory diets and fatigue. Nutrients. 2019;11:2315. doi: 10.3390/nu11102315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102315</ArticleId><ArticleId IdType="pmc">PMC6835556</ArticleId><ArticleId IdType="pubmed">31574939</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebremeskel S, Schanin J, Coyle KM, Butuci M, Luu T, Brock EC, et al. Mast cell and Eosinophil Activation are Associated with COVID-19 and TLR-Mediated viral inflammation: implications for an anti-siglec-8 antibody. Front Immunol. 2021;12:650331. doi: 10.3389/fimmu.2021.650331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.650331</ArticleId><ArticleId IdType="pmc">PMC7988091</ArticleId><ArticleId IdType="pubmed">33777047</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19 hyperinflammation. and post-Covid-19 illness may be rooted in mast cell activation syndrome - International Journal of Infectious Diseases [Internet]. [cited 2022 Aug 9]. Available from: https://www.ijidonline.com/article/S1201-9712(20)30732-3/fulltext</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Histamine and histamine intolerance | The American Journal of Clinical Nutrition. | Oxford Academic [Internet]. [cited 2022 Aug 9]. Available from: https://academic.oup.com/ajcn/article/85/5/1185/4633007.</Citation></Reference><Reference><Citation>S&#xe1;nchez-P&#xe9;rez S, Comas-Bast&#xe9; O, Rabell-Gonz&#xe1;lez J, Veciana-Nogu&#xe9;s MT, Latorre-Moratalla ML, Vidal-Carou MC. Biogenic Amines in Plant-Origin Foods: are they frequently underestimated in low-histamine diets? Foods. Volume 7. Multidisciplinary Digital Publishing Institute; 2018. p. 205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306728</ArticleId><ArticleId IdType="pubmed">30558197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jill Schofield. Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On. Eur J Case Rep Intern Med [Internet]. 2021 [cited 2022 Aug 9]; Available from: https://www.ejcrim.com/index.php/EJCRIM/article/view/2378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046288</ArticleId><ArticleId IdType="pubmed">33869099</ArticleId></ArticleIdList></Reference><Reference><Citation>Abed H, Ball PA, Wang L-X. Diagnosis and management of postural orthostatic tachycardia syndrome: a brief review. J Geriatr Cardiol JGC. 2012;9:61&#x2013;7. doi: 10.3724/SP.J.1263.2012.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/SP.J.1263.2012.00061</ArticleId><ArticleId IdType="pmc">PMC3390096</ArticleId><ArticleId IdType="pubmed">22783324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li Y, Yue Y, Yuan C, Kang JH, Chavarro JE, et al. Adherence to healthy Lifestyle prior to infection and risk of Post&#x2013;COVID-19 Condition. JAMA Intern Med. 2023;183:232&#x2013;41. doi: 10.1001/jamainternmed.2022.6555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.6555</ArticleId><ArticleId IdType="pmc">PMC9989904</ArticleId><ArticleId IdType="pubmed">36745445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kershaw CD, Guidot DM. Alcoholic lung disease. Alcohol Res Health. 2008;31:66&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3860447</ArticleId><ArticleId IdType="pubmed">23584753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamer M, Kivim&#xe4;ki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184&#x2013;7. doi: 10.1016/j.bbi.2020.05.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.059</ArticleId><ArticleId IdType="pmc">PMC7245300</ArticleId><ArticleId IdType="pubmed">32454138</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 patients with documented. alcohol use disorder or alcohol&#x2010;related complications are more likely to be hospitalized and have higher all&#x2010;cause mortality - Bailey &#x2013; 2022 - Alcoholism: Clinical and Experimental Research - Wiley Online Library [Internet]. [cited 2022 Aug 9]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/acer.14838?campaign=wolearlyview.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.14838?campaign=wolearlyview</ArticleId><ArticleId IdType="pmc">PMC9111368</ArticleId><ArticleId IdType="pubmed">35429004</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictive values of tumor necrosis. factor-&#x3b1; for depression treatment outcomes: effect modification by hazardous alcohol consumption | Translational Psychiatry [Internet]. [cited 2022 Aug 9]. Available from: https://www.nature.com/articles/s41398-021-01581-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8413287</ArticleId><ArticleId IdType="pubmed">34475376</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontiers | The Impact of Alcohol Use Disorder on Tuberculosis. : A Review of the Epidemiology and Potential Immunologic Mechanisms [Internet]. [cited 2022 Aug 9]. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2022.864817/full.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9009367</ArticleId><ArticleId IdType="pubmed">35432348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeligar SM, Chen MM, Kovacs EJ, Sisson JH, Burnham EL, Brown LAS. Alcohol and Lung Injury and Immunity. Alcohol Fayettev N. 2016;55:51&#x2013;9. doi: 10.1016/j.alcohol.2016.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2016.08.005</ArticleId><ArticleId IdType="pmc">PMC5319482</ArticleId><ArticleId IdType="pubmed">27788778</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcohol use disorder. : A pre-existing condition for COVID-19? - ScienceDirect [Internet]. [cited 2022 Aug 9]. Available from: https://www.sciencedirect.com/science/article/pii/S0741832920302913.</Citation></Reference><Reference><Citation>Impact of Tobacco Smoking on the Risk of COVID-19. : A Large Scale Retrospective Cohort Study | Nicotine &amp; Tobacco Research | Oxford Academic [Internet]. [cited 2022 Aug 9]. Available from: https://academic.oup.com/ntr/article/23/8/1398/6073671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953961</ArticleId><ArticleId IdType="pubmed">33420786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yordanov Y, Dinh A, Bleibtreu A, Mensch A, Lescure F-X, Debuc E, et al. Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study. Clin Microbiol Infect Elsevier. 2021;27:1158&#x2013;66. doi: 10.1016/j.cmi.2021.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.04.010</ArticleId><ArticleId IdType="pmc">PMC8076762</ArticleId><ArticleId IdType="pubmed">33915287</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoking. and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort | Thorax [Internet]. [cited 2022 Aug 9]. Available from: https://thorax.bmj.com/content/77/1/65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483921</ArticleId><ArticleId IdType="pubmed">34580193</ArticleId></ArticleIdList></Reference><Reference><Citation>Patanavanich R, Glantz SA. Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis. BMC Public Health. 2021;21:1554. doi: 10.1186/s12889-021-11579-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11579-x</ArticleId><ArticleId IdType="pmc">PMC8366155</ArticleId><ArticleId IdType="pubmed">34399729</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;l&#xe9;my H, Mougenot E, Duracinsky M, Salmon-Ceron D, Bonini J, P&#xe9;retz F, et al. Smoking increases the risk of post-acute COVID-19 syndrome: results from a french community-based survey. Volume 20. Tob Induc Dis. The International Society for the Prevention of Tobacco Induced Diseases; 2022. pp. 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9204712</ArticleId><ArticleId IdType="pubmed">35799625</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza FR, Motta-Santos D, dos Santos Soares D, de Lima JB, Cardozo GG, Guimar&#xe3;es LSP, et al. Association of physical activity levels and the prevalence of COVID-19-associated hospitalization. J Sci Med Sport. 2021;24:913&#x2013;8. doi: 10.1016/j.jsams.2021.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsams.2021.05.011</ArticleId><ArticleId IdType="pmc">PMC8141261</ArticleId><ArticleId IdType="pubmed">34090826</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallis R, Young DR, Tartof SY, Sallis JF, Sall J, Li Q et al. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients. Br J Sports Med. BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine; 2021;55:1099&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">33849909</ArticleId></ArticleIdList></Reference><Reference><Citation>Udina C, Ars J, Morandi A, Vilar&#xf3; J, C&#xe1;ceres C, Inzitari M. Rehabilitation in Adult Post-COVID-19 Patients in Post-Acute Care with Therapeutic Exercise. J Frailty Aging. 2021;10:297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876526</ArticleId><ArticleId IdType="pubmed">34105716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebello CJ, Axelrod CL, Reynolds CF, Greenway FL, Kirwan JP. Exercise as a moderator of persistent neuroendocrine symptoms of COVID-19. Exerc Sport Sci Rev. 2022;50:65&#x2013;72. doi: 10.1249/JES.0000000000000284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/JES.0000000000000284</ArticleId><ArticleId IdType="pmc">PMC8900884</ArticleId><ArticleId IdType="pubmed">35019862</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent Exertional Intolerance after COVID-19: insights from Invasive Cardiopulmonary Exercise Testing. Volume 161. CHEST. Elsevier;; 2022. pp. 54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranauskas MN, Carter SJ. Evidence for impaired chronotropic responses to and recovery from 6-minute walk test in women with post-acute COVID-19 syndrome. Exp Physiol. 2022;107:722&#x2013;32. doi: 10.1113/EP089965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089965</ArticleId><ArticleId IdType="pmc">PMC8667649</ArticleId><ArticleId IdType="pubmed">34761446</ArticleId></ArticleIdList></Reference><Reference><Citation>IJERPH | Free Full-Text. | The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study [Internet]. [cited 2022 Aug 9]. Available from: https://www.mdpi.com/1660-4601/19/9/5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerasola D, Argano C, Corrao S, Lessons From. COVID-19: Physical Exercise Can Improve and Optimize Health Status. Front Med [Internet]. 2022 [cited 2022 Aug 28];9. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2022.834844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9136917</ArticleId><ArticleId IdType="pubmed">35646959</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley JH, Sampsel S, Abramoff BA, Herman E, Neerukonda KV, Mikkelsen ME. Consensus methodology for the development of postacute sequelae of SARS-CoV&#x2010;2 guidance statements. PM&amp;R. 2021;13:1021&#x2013;6. doi: 10.1002/pmrj.12670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12670</ArticleId><ArticleId IdType="pmc">PMC8441918</ArticleId><ArticleId IdType="pubmed">34240583</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstructive Sleep Apnea and Risk of COVID-19. Infection, Hospitalization and Respiratory Failure | SpringerLink [Internet]. [cited 2022 Aug 9]. Available from: https://link.springer.com/article/10.1007/s11325-020-02203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63:1500&#x2013;15. doi: 10.1007/s00125-020-05180-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05180-x</ArticleId><ArticleId IdType="pmc">PMC7256180</ArticleId><ArticleId IdType="pubmed">32472191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Restless legs syndrome is associated with long-COVID in women. J Clin Sleep Med American Academy of Sleep Medicine 18:1413&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059584</ArticleId><ArticleId IdType="pubmed">35484639</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer AMPAGelrud, Shiro A, Barr, Carl. Amid the pandemic, Black and Latino men have experienced the largest drop in life expectancy [Internet]. Brookings. 2021 [cited 2022 Aug 12]. Available from: https://www.brookings.edu/research/amid-the-pandemic-black-and-latino-men-have-experienced-the-largest-drop-in-life-expectancy/.</Citation></Reference><Reference><Citation>BERGER Z, ALTIERY DE JESUS V, ASSOUMOU SA, GREENHALGH T. Long COVID and Health Inequities: the role of primary care. Milbank Q. 2021;99:519&#x2013;41. doi: 10.1111/1468-0009.12505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12505</ArticleId><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Equity &#x2014; Are We Finally on the Edge of a New. Frontier? | NEJM [Internet]. [cited 2022 Aug 9]. Available from: https://www.nejm.org/doi/full/10.1056/NEJMp2005944.</Citation></Reference><Reference><Citation>Rossen LM, Ahmad FB, Anderson RN, Branum AM, Du C, Krumholz HM, et al. Disparities in excess Mortality Associated with COVID-19 &#x2014; United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:1114&#x2013;9. doi: 10.15585/mmwr.mm7033a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7033a2</ArticleId><ArticleId IdType="pmc">PMC8375709</ArticleId><ArticleId IdType="pubmed">34411075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D-C, Liang H, Shi L. The convergence of racial and income disparities in health insurance coverage in the United States. Int J Equity Health. 2021;20:96. doi: 10.1186/s12939-021-01436-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01436-z</ArticleId><ArticleId IdType="pmc">PMC8025443</ArticleId><ArticleId IdType="pubmed">33827600</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed ST, Gerber BS, Sharp LK. Traveling towards Disease: transportation barriers to Health Care Access. J Community Health. 2013;38:976&#x2013;93. doi: 10.1007/s10900-013-9681-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-013-9681-1</ArticleId><ArticleId IdType="pmc">PMC4265215</ArticleId><ArticleId IdType="pubmed">23543372</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5:361&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9397704</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasco F, Yang DM, Zhang M, Nelson T, Sheffield T, Keller T, et al. Association of Healthcare Access with Intensive Care Unit utilization and mortality in patients of hispanic ethnicity hospitalized with COVID-19. J Hosp Med. 2021;16:659&#x2013;66. doi: 10.12788/jhm.3717.</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3717</ArticleId><ArticleId IdType="pmc">PMC8577697</ArticleId><ArticleId IdType="pubmed">34730508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington K, Ridge DT, Igwesi-Chidobe CN, Chew-Graham CA, Little P, Babatunde O, et al. A relational analysis of an invisible illness: a meta-ethnography of people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their support needs. Soc Sci Med. 2020;265:113369. doi: 10.1016/j.socscimed.2020.113369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113369</ArticleId><ArticleId IdType="pubmed">33039734</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers MH. Life at work with &#x201c;invisible&#x201d; chronic illness (ICI): the &#x201c;unseen&#x201d;, unspoken, unrecognized dilemma of disclosure. J Workplace Learn MCB UP Ltd. 1997;9:240&#x2013;52. doi: 10.1108/13665629710190040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/13665629710190040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x201c;right&#x201d; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open 4:bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Samulowitz A, Gremyr I, Eriksson E, Hensing G. Brave Men&#x201d; and &#x201c;Emotional Women&#x201d;: a theory-guided literature review on gender Bias in Health Care and gendered norms towards patients with Chronic Pain. Pain Res Manag. 2018;2018:6358624. doi: 10.1155/2018/6358624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6358624</ArticleId><ArticleId IdType="pmc">PMC5845507</ArticleId><ArticleId IdType="pubmed">29682130</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderone KL. The influence of gender on the frequency of pain and sedative medication administered to postoperative patients. Sex Roles. 1990;23:713&#x2013;25. doi: 10.1007/BF00289259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00289259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EH, Shofer FS, Dean AJ, Hollander JE, Baxt WG, Robey JL, et al. Gender disparity in analgesic treatment of emergency department patients with acute abdominal pain. Acad Emerg Med Off J Soc Acad Emerg Med. 2008;15:414&#x2013;8. doi: 10.1111/j.1553-2712.2008.00100.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2008.00100.x</ArticleId><ArticleId IdType="pubmed">18439195</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ebinger JE, Mostafa R, Budde P, Gajewski J, Walker B, et al. Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. J Transl Med. 2021;19:524. doi: 10.1186/s12967-021-03184-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03184-8</ArticleId><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>